Fig. 1 | Hypertension Research

Fig. 1

From: Regression of left ventricular hypertrophy

Fig. 1

Schema of pharmacological, non-pharmacological, and lifestyle modifications that contribute to recovery from left ventricular hypertrophy. ACEi angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, ARNI angiotensin receptor-neprilysin inhibitor, CCB calcium channel blocker, LVAD Left ventricular assist device, LVH left ventricular hypertrophy, MRA mineralcorticoid antagonist, SAVR surgical aortic valve replacement, SGLT-2i sodium–glucose cotransporter-2 inhibitor, TAVI transcatheter aortic valve implantation

Back to article page